Novo Nordisk
NVO
$122.75
Share price
-1.43%
Change (1 day)
44.60%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Number of shares outstanding for Novo Nordisk (NVO)
Number of shares outstanding as of April 2024 : 4,476,900,000
According to Novo Nordisk's latest financial reports and stock price the company's current number of shares outstanding is 4,476,900,000. At the end of 2023 the company had 4,476,900,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Novo Nordisk from 2023 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 4.47 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 26.14% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | -78.79% | 🇺🇸 USA |
 Sanofi SNY | 2,507,200,000 | -44.00% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 2,057,000,000 | -54.05% | 🇺🇸 USA |